Clinical Evolution of Patients with Schizophrenia Associated with Addictive Disorders

1. Jablensky A. The diagnostic concept of schizophrenia: it’s history, evolution and future prospects. Dialogues in Clinical Neuroscience. 2010;12(3):271-287.10.31887/DCNS.2010.12.3/ajablenskySearch in Google Scholar

2. Warner R, De Girolamo G. Schizophrenia. Epidemiology of mental disorders and psychosocial problems. World Health Organization Geneva. 1995:1-6.Search in Google Scholar

3. Nireștean A. Psychiatry Course. Tîrgu Mureș. 2005:92-98.Search in Google Scholar

4. Lampe L, Malhi GS. Avoidant personality disorder. Current insights Psychology Behavioral Management. 2018;11:55–66.10.2147/PRBM.S121073Search in Google Scholar

5. McGrath J, Saha S et al. Epidemiologic reviews. Oxford Academic. 2008;30(1):67-76.Search in Google Scholar

6. Lieberman JA, Bowers J. Substance Abuse in Schizophrenia. Schizophrenia Bulletin. 1990;16(1):29-30.10.1093/schbul/16.1.29Search in Google Scholar

7. Sinclair JMD, Zhao S, Fang Qi, Nyakyoma K, Kwong SWJ, Adams EC. Electroconvulsive therapy for treatment-resistant schizophrenia. Cochrane Database System Review. 2019;(3):CD01184-7.10.1002/14651858.CD011847.pub2Search in Google Scholar

8. World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders, Clinical descriptions and diagnostic guidelines; Geneva; 1992.Search in Google Scholar

9. Lambert JRT, Velakoulis D, Pantelis C. Medical comorbidity in schizophrenia. MJA. 2003;178:S67-S70.10.5694/j.1326-5377.2003.tb05311.xSearch in Google Scholar

10. Robert E, Mueser KT. Co-occuring alcohol use disorder and schizophrenia. Alcohol Research and Health. 2002;99-102.Search in Google Scholar

11. Negrete JC, Tempier R. Drug and Alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophrenia Research. 2004;157-166.10.1016/S0920-9964(02)00523-6Search in Google Scholar

12. Tsuang TM, Stone SW, Stephen V. Pharaoh-Genes, environment and Schizophrenia. British Journal of Psychiatry. 2001;178 (suppl40): 18-24.10.1192/bjp.178.40.s1811315219Search in Google Scholar

13. Nielsen SM, Toftdahl NG, Nordentoft M. and Hjorthoj G. Association between alcohol, cannabis, and other illicit substance abuse and risk of developing schizophrenia: a nationwide population based register study. Psychol Med. 2017;47(9):1668-1677.10.1017/S003329171700016228166863Search in Google Scholar

14. Lee R. Mistrustful and Misunderstood: A Review of Paranoid Personality Disorder. Current. Behaviour Neuroscience. 2017;4(2):151–165.Search in Google Scholar

15. Correll CU, Schooler NR. Negative symptoms in schizophrenia: A review and clinical guide for recognition, assessment, and treatment. Neuropsychiatry Disorders Treat. 2020;16:519–534.10.2147/NDT.S225643704143732110026Search in Google Scholar

16. Maric PN, Jovicic MJ, Mihaljevic M, Mihaljevic C. Improving current treatments for schizophrenia. 2016;77(7):357-367.Search in Google Scholar

17. Manea M, Manea MC, Puiu MG. Introduction to Psychiatry Volume I. Houston Publishing House. 2019;142-174;189-200.Search in Google Scholar

18. Sagud M. Nicotine dependence in Croatian male inpatients with Schizophrenia. BMS Psychiatry. 2018;18-19.10.1186/s12888-018-1606-1577866029357830Search in Google Scholar

19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5 th Edition.American Psychiatric Publishing. 2018;99-105, 481-570.Search in Google Scholar